$12 million for new heart disease and diabetes medical supports
01 Jul 2025
The Australian Government is investing $12 million for the development of locally made medical devices and medicines for people with cardiovascular disease and diabetes. Funding is from the Medical Research Future Fund (MRFF)
Fourteen Australian start-up and innovative companies will receive funding and commercialisation support to develop:
- devices that address atrial fibrillation, ocular drug delivery, high-risk coronary artery disease, cardiogenic shock, stroke, and preeclampsia
- drugs or treatments for kidney disease, acute ischaemic stroke, diabetic retinopathy, atherosclerotic cardiovascular disease, type 1 and 2 diabetes, diabetic kidney disease and peripheral arterial disease.
Funding is from the Targeted Translation Research Accelerator program under the MRFF’s Preventive and Public Health Research initiative. Industry will contribute over $17 million in additional funding to these projects.
Read the media release for more information.
Learn about the MRFF.
